(571) 447-5500
checkmark

The Experts in FDA and USDA Regulatory Matters

EAS Consulting Group is a leading provider of regulatory compliance solutions to industries regulated by FDA, USDA, and supporting agencies. Our team of consultants provide expert guidance for all of your regulatory requirements.

EAS Food Industry Services

Food

Learn More

dietary supplements

Dietary Supplements

Learn More

pharmaceuticals

Pharmaceuticals

Learn More

EAS Medical Devices Services

Medical Devices

Learn More

EAS Tobacco Services

Tobacco

Learn More

cosmetics

Cosmetics

Learn More

EAS Veterinary Services

Veterinary

Learn More

EAS Cannabis Services

Cannabis

Learn More

Learn With Us

Seminars

Transition from Computer System Validation (CSV) to Computer Software Assurance (CSA)

Transition from Computer System Validation (CSV) to Computer Software Assurance (CSA)

The life science industries, including pharmaceutical, medical device, biotechnology, biological, and tobacco and tobacco-related products continue to embrace new technology to improve delivery of quality products in compliance with FDA. In addition, we’ve seen a trend toward making use of cloud services, Software-as-a-Service (SaaS) solutions, and other technical innovations such as use of Artificial Intelligence (AI), Machine Learning (ML) and Large Language Models (LLMs), such as ChatGPT that have more recently begun to be used more heavily in life science companies.

Learn more

Webinars

Animal Food GRAS: Unpacking the Essentials

Animal Food GRAS: Unpacking the Essentials

Presented by Dr. Adam Orr and Tim LombardoJune 17, 2026 | 3:00 PM ETThe U.S. is one of the most promising and expansive markets for innovative animal food ingredients. However, accessing the US requires knowledge about its regulatory requirements. Among the regulatory...

Learn more

On Demand Webinars

Responding to Food and Seafood FDA 483s

Responding to Food and Seafood FDA 483s

When the FDA issues a Form 483 or Warning Letter, your response is critical—and time-sensitive. How you respond can directly impact regulatory outcomes, enforcement risk, and your firm’s credibility.

This webinar will walk through FDA expectations for responding to inspectional observations, along with proven strategies for developing clear, complete, and effective responses. Attendees will gain practical guidance on crafting responses that not only address findings, but also demonstrate control, accountability, and a path to sustained compliance.

Learn more

Latest News

Responding to Food and Seafood FDA 483s

When the FDA issues a Form 483 or Warning Letter, your response is critical—and time-sensitive. How you respond can directly impact regulatory outcomes, enforcement risk, and your firm’s credibility.

This webinar will walk through FDA expectations for responding to inspectional observations, along with proven strategies for developing clear, complete, and effective responses. Attendees will gain practical guidance on crafting responses that not only address findings, but also demonstrate control, accountability, and a path to sustained compliance.

Marty Makary Resigns as FDA Commissioner

Marty Makary Steps Down as FDA Commissioner Multiple news outlets are reporting that Dr. Marty Makary has resigned as Commissioner of the U.S. Food and Drug Administration after serving in the role...

Get the Newsletter

Subscribe to EASeNews and join the nearly 20,000 who receive the monthly EASeNews regulatory newsletter.

Need Regulatory Support?

Start the Conversation Today